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Background: MiRNAs are essential mediators of many biological processes. The aim of this study was to investigate
the dynamics of miRNA-mRNA regulatory networks during exercise and the subsequent recovery period.
Results: Here we monitored the transcriptome changes using microarray analysis of the whole blood of eight
highly trained athletes before and after 30 min of moderate exercise followed by 30 min and 60 min of recovery
period. We combined expression profiling and bioinformatics and analysed metabolic pathways enriched with
differentially expressed mRNAs and mRNAs which are known to be validated targets of differentially expressed
miRNAs. Finally we revealed four dynamically regulated networks comprising differentially expressed miRNAs and
their known target mRNAs with anti-correlated expression profiles over time. The data suggest that hsa-miR-21-5p
regulated TGFBR3, PDGFD and PPM1L mRNAs. Hsa-miR-24-2-5p was likely to be responsible for MYC and KCNJ2
genes and hsa-miR-27a-5p for ST3GAL6. The targets of hsa-miR-181a-5p included ROPN1L and SLC37A3. All these
mRNAs are involved in processes highly relevant to exercise response, including immune function, apoptosis,
membrane traffic of proteins and transcription regulation.
Conclusions: We have identified metabolic pathways involved in response to exercise and revealed four miRNA-mRNA
networks dynamically regulated following exercise. This work is the first study to monitor miRNAs and mRNAs in parallel
into the recovery period. The results provide a novel insight into the regulatory role of miRNAs in stress adaptation.
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MiRNAs are one family of small (20–22 nucleotides)
non-coding RNAs. They regulate gene expression post-
transcriptionally through binding to the complementary
sites of target mRNAs in the 3′-UTR, and play an import-
ant role in regulating diverse biological processes [1].
Recently, miRNA have been demonstrated as regulators
of processes involved in physiological stress adaptation,
including inflammation [2], angiogenesis [3], mitochon-
drial metabolism [4], muscle force generation [5]. However,
just a few studies were published to date describing the
changes in miRNA expression during exercise of different
intensity [6-12]. They did not include the analysis of post-* Correspondence: timur.samatov@gmail.com;
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distribution, and reproduction in any mediumexercise recovery period and thus provided no informa-
tion concerning dynamics of the predicted miRNA-mRNA
regulatory pairs. Detailed investigation of miRNA-mRNA
networks specifically regulated by exercise could reveal
important biomarkers of exercise physiology and would
provide for deep insight into the molecular control of
the stress response.
MiRNAs regulate target gene expression in different
ways including mRNA degradation and translation in-
hibition [1]. The target genes which were regulated by
miRNAs through mRNA degradation are anti-correlated
with the miRNA regulators. In this study, for the first
time whole transcriptome changes were monitored dur-
ing exercise followed by 30 min and 60 min of recovery
period and differentially expressed mRNAs and miRNAs
were analysed resulting in identification of four dynam-
ically regulated miRNA-mRNA networks.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 2 Aminoacids before and in response to exercise
BCAA, μM Cit/Orn Met-SO/Met Tyr/Phe
Pre 567.63 ± 172.16 0.35 ± 0.09 2.28 ± 1.73 0.83 ± 0.15
Post (E) 612.83 ± 99.68 0.34 ± 0.11 0.92 ± 0.21 0.91 ± 0.18
Rest 30 min (R1) 496.89 ± 128.31 0.42 ± 0.09 1.71 ± 0.92 0.91 ± 0.19
Rest 60 min (R2) 417.75 ± 58.2 0.5 ± 0.15 1.21 ± 0.47 0.9 ± 0.16
Abbreviations: BCAA Branched-Chain Amino Acids, Cit Citrulline, Orn ornithine,
Met-SO Methionine Sulfoxide, Met Methionine, Tyr Tyrosine, Phe Phenylalanine.
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Anthropometric and physiological data
To exclude possible effects of gender, only male subjects
were recruited for this study. Anthropometric and physio-
logical parameters of athletes are presented in Table 1.
Before exercise the serum lactate level was 1.7 ± 0.4 mM.
After exercise, it was mildly elevated, but still below
4.0 mM, confirming that the exercise performed was
moderate without transgression of the anaerobic threshold.
Branched-chain amino acids (BCAA) include three struc-
turally related amino acids Leucine (Leu), Isoleucine (Ile),
and Valine (Val). The initial steps of their degradation are
catalyzed by the same set of mitochondrial enzymes, and
therefore, the BCAA behave as a very homogenous group.
Their regulation is performed by short-term metabolic
control reflecting consuming of energy sources. It has
been shown previously that an acute bout of prolonged
exercise increases the rate of BCAA oxidation by skel-
etal muscle [13]. We observed a slight increase in the
BCAA level immediately after exercise followed by a
decline below base level during recovery (Table 2). The
ratio of citrulline (Cit) to ornithine (Orn) is indicative
of the ornithine carbamoylphosphate transferase activity
and characterizes the regulation of the urea cycle path-
way [14]. This ratio had a tendency to increase (Table 2).
The ratios of methionine sulfoxide (Met-SO) to methio-
nine (Met) and tyrosine (Tyr) to phenylalanine (Phe)
indicate oxidative stress [15,16]. We found a decrease in
Met-SO/Met and a slight increase in Tyr/Phe (Table 2).
The data summarized in Table 2 confirmed that the
exercise was moderate and athletes reacted as normal
healthy subjects [17].
Flow cytometry analysis
Changes in white blood cell subpopulations in response to
exercise are presented in Table 3. Total white blood cell
counts revealed the expected exercise-induced leukocytosis.
NK lymphocytes (defined as CD3–, CD16/56+) substan-
tially contributed to the observed changes which was con-
sistent with the published data [18]. However NK-specific
mRNAs (e.g., coding for KIR receptors) in the wholeTable 1 Anthropometric and physiological data
Parameter Value
Age (year) 21.7 ± 2.6
Body mass (kg) 74.9 ± 2.3
Height (cm) 185.3 ± 3.5
Body mass index (kg/m2) 21.8 ± 1.2
Heart rate before exercise(bpm) 57.3 ± 1.9
Heart rate after exercise (bpm) 179.4 ± 3.2
Blood pressure before exercise (mmHg) 120/66 ± 3/2
VO2max (ml min
-1 kg-1) 74.8 ± 3.3
Values are mean ± SD.blood did not demonstrate similar nearly 3-fold increase
(see Additional file 1) thus confirming that our subsequent
microarray analysis showed true changes in RNA expression.
miRNA and mRNA differential expression profiles
The miRNA and mRNA expression profiles in the whole
blood for each time point and each athlete were determined
using microarray analysis. PAXgene RNA tubes enable the
isolation of intracellular RNA of circulating leukocytes,
including B cells, T cells, neutrophils, monocytes, and
other less abundant cell types. Furthermore, a large pro-
portion of reticulocyte-derived globin mRNA is prepared
from PAXgene blood RNA tubes, as it has been demon-
strated previously [19]. Affymetrix GeneChip Human Gene
1.0 ST arrays contain both miRNA and mRNA probes
and are capable of measuring about 20,000 mRNAs and
200 miRNAs.
The data are presented in Additional file 1. 298 mRNAs
and 5 miRNAs were changed significantly (at least 40%
change with the adjusted P-value threshold of 0.05),
including hsa-miR-21-5p, hsa-miR-24-2-5p, hsa-miR-27a-
5p, hsa-miR-181a-5p and hsa-miR-181b-5p. Remarkably,
hsa-miR-24-2-5p is clustered with hsa-miR-27a-5p, and
hsa-miR-181a-5p is clustered with hsa-miR-181b-5p.
Consistently, the clustered miRNAs exhibited similar
expression profiles over time (see Additional file 1 and
Figures 1, 2, 3 and 4).
Pathway analysis of differentially expressed mRNAs
All 298 differentially expressed mRNAs were analysed
for enriched metabolic pathways. Table 4 indicates the
revealed pathways including immune response and gly-
coproteins. As expected, they were previously reported
to be associated with exercise [6,8] thus confirming the
relevance of our experimental model.
Pathway analysis of mRNA targets of differentially
expressed miRNAs
All 5 differentially expressed miRNAs have 1136 validated
target mRNAs in total. We performed pathway enrich-
ment analysis for these mRNAs (Table 5). Again, the
revealed pathways are highly relevant to exercise, e.g.
transcription regulation, apoptosis, response to stress etc.
It has been demonstrated that the same mRNAs can
be targeted by more than one miRNA which provides
Table 3 Changes in white blood cell subpopulations in response to an exercise
Pre Post (E) Fold change
relativeAbsolute, cells/ul Relative, % Absolute, cells/ul Relative, %
WBC 5710 ± 1170 7705 ± 2000
LY 2387 ± 674 41.8 ± 11.8 3989 ± 932 69.9 ± 12.1 1.67
СD3+ 1616 ± 549 28.3 ± 9.6 2349 ± 901 41.1 ± 11.7 1.45
СD3 + CD4+ 1020 ± 413 17.9 ± 7.2 1189 ± 419 20.8 ± 5.4 1.17
СD3 + CD8+ 596 ± 265 10.4 ± 4.6 1124 ± 532 19.7 ± 6.9 1.89
СD3-CD16+ 494 ± 203 8.7 ± 3.6 1380 ± 523 24.2 ± 6.8 2.79
СD3-CD56+ 393 ± 217 6.9 ± 3.8 1111 ± 468 19.5 ± 6.1 2.83
CD19+ 227 ± 124 4.0 ± 2.2 308 ± 221 5.4 ± 2.9 1.36
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Figure 1 Expression profiles of hsa-miR-21-5p and its target mRNAs. (A-H) the tested athletes. E, after 30 min of exercise; R1, after 30 min
relaxation; R2, after 60 min relaxation. Bold blue, hsa-miR-21-5p; brown, TGFBR3; green, PDGFD; violet, PPM1L; light blue, RHOBTB3. Solid lines
indicate validated mRNA targets and dashed line indicates predicted potential mRNA target.

























































































E R1 R2 E R1 R2
E R1 R2 E R1 R2
E R1 R2 E R1 R2
E R1 R2 E R1 R2
Figure 2 Expression profiles of hsa-miR-24-2-5p and its target mRNAs. (A-H) the tested athletes. E, after 30 min of exercise; R1, after 30 min
relaxation; R2, after 60 min relaxation. Bold blue, hsa-miR-24-2-5p; brown, MYC; green, KCNJ2. Solid line indicates validated mRNA target and
dashed line indicates predicted potential mRNA target.
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found 49 mRNAs which are known to be validated targets
for 2 or even 3 differentially expressed miRNAs. They
have higher potential to be involved in exercise-induced
regulation. Table 6 shows the pathways enriched with
some of these mRNAs. Notably, these exercise-relevant
pathways (cell death, stress response, proliferation) com-
prise significant number of intersecting mRNAs. Figure 5
presents the identified regulatory miRNA-mRNA network
for all 3 revealed pathways. Interestingly, some of these
genes are known to interact with each other. Namely
transcription factor MYC was reported to be functionally
associated with RNA helicase DDX3X [22], apoptosis
regulator BCL2 [23] and tumor suppressor BRCA1 [24].
BRCA1 in turn interacts itself with BCL2 [25] and tran-
scription factor E2F1 [26]. The presented data support
the regulatory role of identified miRNAs in response
to exercise.Dynamically regulated miRNA-mRNA networks
We monitored the transcriptome expression level before
and following exercise and this allowed us to reveal dy-
namically regulated miRNA-mRNA networks. We used
a two-step approach to identify the mRNA targets for
the differentially expressed miRNAs. First, we looked for
anti-correlating groups of miRNAs and mRNAs expres-
sion of which over time tended to have opposite profiles.
Target mRNA degradation is one of the mechanisms
of miRNA action when their perfect complementarity
occurs [1,27]. Thus, the second step of our strategy was
either analysis of published data and selection of experi-
mentally validated target mRNAs for a given miRNA or
theoretical prediction of miRNA targets based on their
complementarity, using one of the most popular web
resources TargetScan [28]. The expression profiles and
biological function of selected miRNAs and mRNAs were
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Figure 3 Expression profiles of hsa-miR-27a-5p and its target mRNA. (A-H) the tested athletes. E, after 30 min of exercise; R1, after 30 min
relaxation; R2, after 60 min relaxation. Bold blue, hsa-miR-27a-5p; dashed brown, predicted potential target mRNA ST3GAL6.
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being involved in the regulation of exercise-related physio-
logical processes.
hsa-miR-21-5p
MiRNA hsa-miR-21-5p demonstrated different expression
profiles over time (adjusted P-value 0.0039) however
remarkably anti-correlating with experimentally validated
target mRNAs TGFBR3 (adjusted P-value 1.079E-06),
PDGFD (adjusted P-value 1.28E-06) and PPM1L (adjusted
P-value 6.78E-07) (Figure 1). RHOBTB3 mRNA (adjusted
P-value 0.002) predicted by TargetScan to be a potential
target for hsa-miR-21-2-5p behaved similarly. We ob-
served the up-regulation of hsa-miR-21-5p one hour
after exercise. The differences in kinetics can be po-
tentially explained by individualities of each athlete.
The expression level of hsa-miR-21-5p itself is known to
be stress-responsive and play an important role in heart
failure [29] and renal ischemia reperfusion injury [30].Notably the up-regulation of circulating hsa-miR-21-5p
was recently reported to occur in plasma upon exercise
[6]. The overall action of hsa-miR-21-5p has been de-
scribed by several authors to be strongly anti-inflammatory
[6,31]. Note, that 60 min into relaxation, there was an
up-regulation of hsa-miR-21-5p in all 8 subjects. This
may reflect the self-protective anti-inflammatory reac-
tion to exercise.
We identified four pairing targets for this miRNA namely
TGFBR3, PDGFD, PPM1L, and RHOBTB3. TGFBR3 is a
transforming growth factor (TGF)-beta type III receptor,
mRNA of which is known to be up-regulated in the
peripheral blood leukocytes in allograft rejection-prone
recipients after intestinal transplantation thus mediating
innate and adaptive inflammatory functions of leukocytes
[32]. PDGFD encodes for platelet derived growth factor
D [33], a member of the platelet-derived growth factor
family which can regulate many cellular processes, includ-
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Figure 4 Expression profiles of hsa-miR-181a-5p and its validated target mRNAs. (A-H) the tested athletes. E, after 30 min of exercise; R1, after
30 min relaxation; R2, after 60 min relaxation. Bold blue, hsa-miR-181a-5p; brown, ROPN1L; green, SCL37A3.
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a protein phosphatase gene [35] responsible for the
regulation of stress-activated protein kinase signaling
cascade and apoptosis [36]. Finally, the fourth identified
target for hsa-miR-21-5p is RHOBTB3 mRNA [33] which
encodes for the Rho GTPase regulating the membrane
traffic of proteins [37]. Interestingly, this mRNA proved to
be a blood biomarker of psychosis and shows a decreased
expression level in high hallucinations states [38].hsa-miR-24-2-5p
MiRNA hsa-miR-24-2-5p (adjusted P-value 0.00017) was
up-regulated immediately after exercise, then tended to
decrease during the recovery period except athlete D
(Figure 2). In our study for the first time we report the
reaction to exercise of this miRNA which is known to
have protective effects on myocytes against myocardial
ischaemia/reperfusion-induced apoptosis [39].MYC mRNA (adjusted P-value 0.00013) which is known
to be the target for this miRNA from the literature, and
KCNJ2 mRNA (adjusted P-value 0.00023) predicted by
TargetScan to be a potential target essentially followed
anti-profile of hsa-miR-24-2-5p. The protein encoded
by theMYC gene is a multifunctional, nuclear phosphopro-
tein that plays a role in cell cycle progression, apoptosis
and cellular transformation. It functions as a transcription
factor that regulates transcription of specific target genes.
Interestingly, hsa-miR-24-2-5p is known to be up-regulated
during hematopoietic cell terminal differentiation sup-
pressing MYC expression [40]. Thus the increase of this
miRNA we observed (Figure 2) may reflect the regula-
tion of hematopoiesis upon exercise. Remarkably, MYC
mRNA is among those which are regulated by 2 dif-
ferentially expressed miRNAs, namely hsa-miR-21-5p
and hsa-miR-24-2-5p (Figure 5), however its expression
profile is anti-correlated with only the profile of hsa-
miR-24-2-5p (Figures 1 and 2).
Table 6 Pathway analysis of mRNAs validated to be
targets for 2 or 3 differentially expressed miRNAs
Pathway Number of genes Adjusted P-value
Cell death 17 7.64E-07
Regulation of cell proliferation 15 2.10E-07
Cellular response to stress 12 5.35E-05






Natural killer cell mediated cytotoxicity 22 1.80E-15
Immune response 13 3.10E-03
Response to wounding 7 8.70E-01
Inflammatory response 7 1.90E-01
Regulation of lymphocyte mediated immunity 5 1.40E-01
Leukocyte activation 5 8.90E-01
Response to mechanical stimulus 3 3.80E-02
Stress response 3 5.90E-02
Cytolysis 3 3.20E-02
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inward-rectifier type potassium channel participating in
establishing the action potential waveform and excit-
ability of neuronal and muscle tissues [41]. This mRNA
expressed in peripheral blood lymphocytes is a biomarker
for Parkinson’s disease [42].hsa-miR-27a-5p
MiRNA hsa-miR-27a-5p is clustered with hsa-miR-24-2-5p
and behaved similarly to it increasing after exercise and
decreasing during the recovery period except athlete D
(Figure 3) with the adjusted P-value 0.00012. This miRNA
was reported to promote myoblast proliferation by redu-
cing the expression of myostatin [43].
The only mRNA target identified is predicted by
TargetScan ST3GAL6. The encoded protein belongs to
the sialyltransferase family and is responsible for the
synthesis of selectin ligands [44].hsa-miR-181a-5p
hsa-miR-181a-5p tended to increase after exercise and
then to down-regulate during the first as well as the
second period of the relaxation time (Figure 4) with anTable 5 Pathway analysis of all validated mRNA targets





Transcription regulation 283 2.03E-13
Apoptotic process 157 2.59E-11
Cell cycle 148 5.95E-12
Regulation of kinase activity 76 1.08E-08
Regulation of cellular response to stress 34 1.63E-04
p53 signaling pathway 19 4.26E-08
E2F transcription factor network 19 1.51E-07
Validated targets of C-MYC transcriptional activation 14 1.08E-03adjusted P-value of 5.83E-05. The observed differential
expression of hsa-miR-181a-5p in our athletes is consist-
ent with previously published results [7,8]. This miRNA
is characterized as a regulator of hematopoietic lineage
differentiation [45] and a modulator of T cell sensitivity
and selection [46]. Radom-Aizik showed up-regulation
of this miRNA after 30 min interval exercise. They re-
lated it to increased T cell responsiveness and reduced
susceptibility to infection due to physical activity. In our
study 7 subjects showed up-regulation immediately after
exercise (Figure 4).
The mRNAs ROPN1L (adjusted P-value 0.00024) and
SLC37A3 (adjusted P-value 0.0019) were previously vali-
dated to be targets for hsa-miR-181a-5p and demonstrated
pronounced anti-correlation with the miRNA expression
profile. The ROPN1L gene encodes a member of the
ropporin family. The encoded protein is involved in the
targeting towards specific physiological substrates of
Protein Kinase A, regulating glycogen, sugar, and lipid
metabolism [47]. The SLC37A3 protein belongs to trans-
membrane sugar transporters and is responsible for sugar
metabolism [48].Conclusion
We have identified metabolic pathways enriched with differ-
entially expressed mRNAs and with mRNA targets of differ-
entially expressed miRNAs, including mRNAs known to be
regulated by 2 or 3 miRNAs described here. The result sup-
ports previously published data. Moreover, we revealed four
miRNA-mRNA networks dynamically regulated following
exercise. These observations provide a novel insight into
the potential regulatory role of miRNAs in the numerous
physiological processes involved in stress adaptation.Methods
Ethical approval and study participants
Eight national level ski athletes took part in this study.
None of them suffered from acute or chronic diseases or
reported intake of medication. Participants were informed
about the nature, purpose, and potential risks of the ex-
periments and signed an informed consent statement
approved by the ethics committee of Scientific Research






















Figure 5 Regulatory network of mRNAs validated to be the targets for 2 or 3 differentially expressed miRNAs. All mRNAs belong to
three enriched pathways listed in Table 6. Red dashed lines connect mRNAs of proteins reported to functionally interact with each other. MYC is
highlighted with red oval indicating that this mRNA was further identified to be a component of dynamically regulated miRNA-mRNA network.
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Height, weight, medical historical data and resting vital
signs were recorded at the time of enrolment.
Exercise test protocol
In order to determine the VO2max values, each subject
performed a treadmill test with an incremental step proto-
col until exhaustion as described previously [47]. VO2max
was calculated as described [49]. The anaerobic threshold
was calculated using the standard V-slope method [50].
Two weeks later, athletes participated in the main exer-
cise, consisting of running at 80% VO2 peak for 30 min on
a treadmill. The exercise was performed during the morn-
ing hours (between 8 and 11 a.m.) keeping the exact test
time for each participant constant.
Lactate concentration
Lactate concentration in capillary blood was measured
electrochemically using the automated analyzer Biosen
C_Line (EFK Diagnostic, Germany).
Analysis of aminoacids
Sera derived from the venous blood samples were
analyzed for aminoacids in Genome Analysis Centre
(Helmholtz Zentrum, Munich, Germany) using the
BIOCRATES AbsoluteIDQ p150 Kit (Biocrates Life Sciences
AG, Innsbruck, Austria) in a combined FIA-MS/MS and
LC-MS/MS assay as recommended by the manufacturer
and described previously [51].Blood sampling
Venous blood was collected at four time points during
the exercise. A 20-gauge intravenous catheter was placed
antiseptically into a dorsal hand vein or a vein in the dis-
tal forearm as dictated by favourable anatomy using the
Seldinger technique and then secured with tape. During
ME 2.5 ml of blood was collected in PAXgene blood RNA
tube, 7 ml in a Serum separator tube (BD, USA) and
4.5 ml in a tube containing buffered tri-sodium citrate
(BD, USA) for flow cytometry analysis at baseline (prior to
exercise testing) and immediately post-exercise (within
1 min of completion of exercise testing). After 30 min
of rest and after 60 min of rest following exercise test-
ing 2.5 ml of blood was collected in PAXgene blood
RNA tubes.
RNA extraction
According to the Affymetrix Manual P/N 701880 Rev. 4
total RNA was extracted using the PAXgene Blood RNA
kit as recommended by the manufacturer. RNA concen-
trations were determined by the Nanodrop photometer
(NanoDrop, USA). RNA quality was checked using the
Agilent Bioanalyser 2100 System (Agilent Technologies,
USA). For all samples RNA integrity number (RIN) was
greater than 7.
Flow cytometry analysis
Flow cytometry analysis of blood samples was performed
using fluorescently labeled antibodies against B and T cell
Tonevitsky et al. BMC Physiology 2013, 13:9 Page 9 of 11
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were labeled with antibodies against CD3 (FITC), CD4
(PE), CD8 (PE), CD16 (FITC), CD56 (PE), CD19 (FITC)
(Sorbent, Russia), where NK cells were distinguished
from the rest of the lymphocytes via positive expression
of CD56 and negative expression of CD3.
The samples were analyzed on a FACScan Calibur flow
cytometer (BD Biosciences, USA) and leukocytes were
gated based on forward and side scatter properties. Events
in the range of 40,000–200,000 were collected depending
on the occurrence of the investigated leukocyte popula-
tion, and analyzed with CELLQuest Pro analysis software
(BD Biosciences, USA). To ensure flow cytometric stan-
dardization, the voltage settings were updated daily using
‘Calibrate Beads’ (BD Biosciences, USA).
Microarray analysis
RNA samples were prepared according to manufacturer’s
instructions (Affymetrix Manual P/N 701880 Rev. 4) as
described elsewhere [52]. The samples were hybridized on
GeneChip Human Gene 1.0 ST Arrays containing both
miRNA and mRNA probes (Affymetrix, USA) for 16 h
at 45°C. Arrays were washed to remove non-specifically
bound nucleic acids and stained on Fluidics Station 450
(Affymetrix) using FS450_0007 protocol followed by scan-
ning on a GeneChip Scanner 3000 7G system (Affymetrix).
The microarray CEL files have been deposited in the GEO
database (accession GSE46075).
Microarray data processing
Microarray data was processed using bioconductor [53]
xps package implementation of RMA [54]. At the first
step background correction was performed based on a
global model for the distribution of probe intensities [54].
Then a quantile normalization algorithm [55] (so-called
probe-level normalization) was applied to the preprocessed
data. Finally, fitting a robust linear model using Tukey’s
median polish procedure [56] was done to convert probe
intensities to the expression levels of probesets.
The statistical analysis of microarray data was performed
using bioconductor [53] package limma [57]. The analysis
was based on a generalized linear model [57,58] approach.
In this approach one constructs a linear data model with a
structure determined by the experiment layout, and then
fits this model to the actual data. The linear model is
defined in terms of a so-called design matrix. The num-
ber of rows in this matrix coincides with the number of
experiment samples, and the number of columns coin-
cides with the number of factors that have an essential
influence on the measurable values. The value at the i-th
row and j-th column of a design matrix specifies an effect
of a factor j on a sample i. Each measurable value (i.e.,
each probeset) in this approach is analysed independently.
For each probeset a vector of its expression values E isrepresented in the form E =Dβ + ε, where D is a design
matrix, β is a vector of coefficients indicating values of
each factor’s actual influence on the analyzed probeset,
ε is a vector of error, and model fitting consists in the
minimization of “error term” ε by finding optimal coeffi-
cients β. After the coefficients β are computed for each
probeset, one can test various hypotheses on the struc-
ture of considered factors. For example, in order to find
probesets that are affected by a factor i, one should
search for the probesets with βi statistically different
from zero.
The general linear model was applied in the analysis of
the studied transcriptome changes as follows. The model
that takes into account both experiment time points and
athletes individual features was used. Thus, the total
number of factors was eleven: c1, …, c8 correspond to
an expression level of each athlete in a normal state (for
all samples the effect of these factors is set to 1 if a sample
and a factor correspond to the same athlete, and set to 0
otherwise), and d1, d2, d3 correspond to the changes
induces by the exercises, exercises and 30-minutes relax-
ation, and exercises and 60-minutes relaxation respect-
ively (for all samples the effect of these factors is set to 1
if a sample and a factor correspond to the same experi-
ment time point, and set to 0 otherwise). The total num-
ber of samples was 32: 4 samples for each athlete.
For each pair of experiment time points the detection
of probesets with reliable difference between time points
was performed. The probeset was considered to have a
reliable difference between time points k, m if an adjusted
p-value of an equality βk = βm (where βl was an actual
influence of exercises at experiment time point for
l = 1,2,3, and β0 = 0) was less than 0.05, and a log-fold
change was greater than 0.484 (this threshold corre-
sponds to an intensity change by more than 40%). The
Benjamini-Hochberg [59] algorithm was used for mul-
tiple testing adjustment. The minimum adjusted p-value
for all pairs of time points is indicated for each differen-
tially expressed probeset in the Table of differentially
expressed mRNAs and miRNAs (Additional file 1) as a
statistical significance value.Pathway analysis
Bioinformatic analysis was performed using DAVID online
tool (http://david.abcc.ncifcrf.gov) as described elsewhere
[60]. So all the analyzed genes were classified into several
functional groups, and the groups that may be potentially
associated with physiological stress were considered and
listed in the tabs of excel document. P-values on the tabs
are modified Fisher Exact P-Values. When members of
two independent groups can fall into one of two mutually
exclusive categories, Fisher Exact test is used to determine
whether the proportions of those falling into each category
Tonevitsky et al. BMC Physiology 2013, 13:9 Page 10 of 11
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Exact test is adopted to measure the gene-enrichment in
annotation terms.
Additional file
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